TCTR20171127003
Recruiting
Phase 2
Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) Using Flattening Filter Free (FFF) in Early Non-small Cell Lung Cancers (NSCLC) and Metastatic Lung Cancers.
none0 sites138 target enrollmentNovember 27, 2017
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- early non-
- Sponsor
- none
- Enrollment
- 138
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with early NSCLC or lung metastases treated with SBRT using FFF.
- •2\. Adequate follow up period of more than 6 months after SBRT
Exclusion Criteria
- •1\. Incomplete documented medical records or inaccessible data
- •2\. Incomplete treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The efficacy of stereotactic body radiation therapy for unresectable hepatocellular carcinoma: a single institution phase II studyKCT0000625Asan Medical Center50
Completed
Not Applicable
Efficacy of stereotactic body radiotherapy in primary renal cell carcinomaKCT0007835Asan Medical Center40
Not yet recruiting
Not Applicable
Stereotactic ablative body radiotherapy for Unresectable Pancreatic cancer with Endoscopic ultrasound inserted fiducial markers and concuRrent chemotherapy (SUPER) trial.Pancreatic cancer tumoursACTRN12617001571369Royal Adelaide Hospital250
Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
Completed
Phase 2
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42